Ironwood Pharma (IRWD)
NASDAQ:IRWD
Holding IRWD?
Track your performance easily

Ironwood Pharma (IRWD) Financial Statements

249 Followers

Ironwood Pharma Financial Overview

Ironwood Pharma's market cap is currently ―. The company's EPS TTM is $-0.015; its P/E ratio is -311.95; Ironwood Pharma is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Jun 23
Income Statement-
Total Revenue$ 91.59M$ 94.40M$ 74.88M$ 117.55M$ 107.38M
Gross Profit$ 91.59M$ 94.40M$ 74.88M$ 1.23B$ 107.38M
EBIT$ 17.35M$ 18.84M$ 12.63M$ 39.99M$ 29.08M
EBITDA$ 18.20M$ 19.90M$ 13.73M$ 40.53M$ 29.83M
Net Income Common Stockholders$ 3.65M$ -860.00K$ -4.16M$ -1.09M$ 43.07M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 88.21M$ 105.52M$ 121.54M$ 92.15M$ 175.32M
Total Assets$ 389.52M$ 395.62M$ 438.82M$ 471.07M$ 603.22M
Total Debt$ 614.87M$ 640.26M$ 690.42M$ 715.54M$ 815.75M
Net Debt$ 526.66M$ 534.73M$ 568.88M$ 623.38M$ 640.43M
Total Liabilities$ 700.85M$ 717.35M$ 769.34M$ 817.37M$ 950.00M
Stockholders Equity$ -311.33M$ -321.73M$ -330.52M$ -346.30M$ -345.70M
Cash Flow-
Free Cash Flow$ 9.87M$ 33.41M$ 44.92M$ 35.62M$ 34.96M
Operating Cash Flow$ 9.88M$ 33.47M$ 44.98M$ 35.83M$ 34.96M
Investing Cash Flow$ -16.00K$ -58.00K$ -68.00K$ -4.19M$ -999.49M
Financing Cash Flow$ -27.16M$ -49.37M$ -15.55M$ -50.90M$ 399.07M
Currency in USD

Ironwood Pharma Earnings and Revenue History

Ironwood Pharma Debt to Assets

Ironwood Pharma Cash Flow

Ironwood Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis